Here, we describe a Chinese infant with elevated liver transaminases, developmental delay, epilepsy (subclinical seizures) and light constipation who possesses two novel compound heterozygous mutations in NGLY1: a missense mutation and a termination mutation. The gene discussed is NGLY1; the disease is epilepsy.